Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Page 1
Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarks.
Ahlskog JE. Ahlskog JE. Parkinsonism Relat Disord. 2024 Apr;121:106037. doi: 10.1016/j.parkreldis.2024.106037. Epub 2024 Feb 10. Parkinsonism Relat Disord. 2024. PMID: 38360506
Long-term Parkinson's disease (PD) progression is not a homogeneous process and manifests in diverse ways over the lifetime. ...
Long-term Parkinson's disease (PD) progression is not a homogeneous process and manifests in diverse ways over the lifetime. . …
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical tests.
Qamar MA, Rota S, Batzu L, Subramanian I, Falup-Pecurariu C, Titova N, Metta V, Murasan L, Odin P, Padmakumar C, Kukkle PL, Borgohain R, Kandadai RM, Goyal V, Chaudhuri KR. Qamar MA, et al. Front Neurol. 2023 May 25;14:1174698. doi: 10.3389/fneur.2023.1174698. eCollection 2023. Front Neurol. 2023. PMID: 37305739 Free PMC article. Review.
In this paper, we discuss possible, simple to use, and clinically relevant tests that can be used to monitor the status of these vitals, so that these can be incorporated into clinical practice. We also use the term Parkinson's syndrome to describe Parkinson's disea …
In this paper, we discuss possible, simple to use, and clinically relevant tests that can be used to monitor the status of these vitals, so …
Configurable Offline Sensor Placement Identification for a Medical Device Monitoring Parkinson's Disease.
Kostikis N, Rigas G, Konitsiotis S, Fotiadis DI. Kostikis N, et al. Sensors (Basel). 2021 Nov 24;21(23):7801. doi: 10.3390/s21237801. Sensors (Basel). 2021. PMID: 34883805 Free PMC article.
In this work we discuss the offline, fixed class, sensor placement identification method implemented in PDMonitor(), a medical device for long-term Parkinson's disease monitoring at home. We analyze the stepwise procedure used to accurately identify the wearables de …
In this work we discuss the offline, fixed class, sensor placement identification method implemented in PDMonitor(), a medical device for lo …
Structured guideline-based physiotherapy reduces difficulties in activities of daily living in Parkinson's disease.
Medijainen K, Pääsuke M, Lukmann A, Taba P. Medijainen K, et al. NeuroRehabilitation. 2022;50(1):47-56. doi: 10.3233/NRE-210181. NeuroRehabilitation. 2022. PMID: 34776423 Free PMC article. Clinical Trial.
BACKGROUND: In the long term, Parkinson's disease (PD) leads to the development of difficulties in daily functional tasks. ...
BACKGROUND: In the long term, Parkinson's disease (PD) leads to the development of difficulties in daily functional tasks. ...
Genetic variants in levodopa-induced dyskinesia (LID): A systematic review and meta-analysis.
Falla M, Di Fonzo A, Hicks AA, Pramstaller PP, Fabbrini G. Falla M, et al. Parkinsonism Relat Disord. 2021 Mar;84:52-60. doi: 10.1016/j.parkreldis.2021.01.020. Epub 2021 Jan 31. Parkinsonism Relat Disord. 2021. PMID: 33561612
INTRODUCTION: Levodopa-induced dyskinesia frequently complicates long-term Parkinson's disease. More in-depth knowledge regarding the role of genetic factors in dyskinesia development may be important to identify parkinsonian patients who are more prone to developin …
INTRODUCTION: Levodopa-induced dyskinesia frequently complicates long-term Parkinson's disease. More in-depth knowledge regard …
William Rutherford Sanders (1828-1881) and his neurologically fertile years (1865-1868).
Eadie M. Eadie M. J Hist Neurosci. 2020 Oct-Dec;29(4):418-427. doi: 10.1080/0964704X.2020.1749370. Epub 2020 Apr 24. J Hist Neurosci. 2020. PMID: 32329662
In arguing that a patient did not have paralysis agitans, Sanders (1865) employed the term "Parkinson's disease" for the first time in the English-language literature to distinguish between the disorder that Parkinson (1817) termed "paralysis agitans" and other type …
In arguing that a patient did not have paralysis agitans, Sanders (1865) employed the term "Parkinson's disease" for the first …
Essential tremor-plus: a controversial new concept.
Louis ED, Bares M, Benito-Leon J, Fahn S, Frucht SJ, Jankovic J, Ondo WG, Pal PK, Tan EK. Louis ED, et al. Lancet Neurol. 2020 Mar;19(3):266-270. doi: 10.1016/S1474-4422(19)30398-9. Epub 2019 Nov 22. Lancet Neurol. 2020. PMID: 31767343 Free PMC article. Review.
If ET-plus had been defined on the basis of a difference in underlying pathology or an appreciable difference in prognosis, it would have a valid, scientific rationale, as does the term Parkinson-plus. However, there is no such evidence, so the basis for the term is …
If ET-plus had been defined on the basis of a difference in underlying pathology or an appreciable difference in prognosis, it would have a …
28 results